Skip to main content

Advertisement

Differences in iNOS inhibition in an animal model of acute hepatic and multi-organ failure

Introduction

iNOS inhibition in AHF is controversial, fuelled by conflicting results from studies using varieties of pharmacological agents, animal models and temporal protocols.

Methods

We have previously described a robust model of acute hepatic and multi-organ failure in the Wistar rat. AHF was induced by two i.p. injections (500 mg/kg, 8 hours apart) of thioacetamide (TAA). Six groups were studied (n = 5). Group 1 received TAA alone. Groups 2, 3 & 4 followed protocol for Group 1, however, Groups 2 & 3 were pre-treated and Groups 4 & 5 post-TAA treated with iNOS inhibitors AMG (100 mg/kg s.c.) and L-NAME (100 mg/kg s.c.) for 5 days.

Results

See Table

Table 1

Conclusion

AMG is a more selective iNOS inhibitor, significantly reducing parameters of AHF compared L-NAME. Beneficial effects are, however, negated if iNOS inhibitors are administered after TAA, exacerbating hepatic injury, increasing mortality, and thus demonstrating temporal constraints.

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Rahman, T., Hodgson, H. Differences in iNOS inhibition in an animal model of acute hepatic and multi-organ failure. Crit Care 5, P082 (2001). https://doi.org/10.1186/cc1149

Download citation

Keywords

  • Public Health
  • Animal Model
  • Beneficial Effect
  • Emergency Medicine
  • Pharmacological Agent